Point72 Hong Kong’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-72,610
Closed -$347K 1819
2022
Q3
$347K Buy
+72,610
New +$383K 0.01% 888
2022
Q2
Sell
-32,798
Closed -$156K 2524
2022
Q1
$156K Buy
32,798
+31,990
+3,959% +$177K 0.01% 1033
2021
Q4
$6K Buy
+808
New +$5.02K ﹤0.01% 1719
2021
Q1
Sell
-2,469
Closed -$16K 2307
2020
Q4
$16K Buy
+2,469
New +$14.4K ﹤0.01% 1470
2019
Q4
Sell
-102
Closed 1516
2019
Q3
$0 Sell
102
-7,975
-99% -$21.2K ﹤0.01% 1425
2019
Q2
$18K Buy
8,077
+7,817
+3,007% +$18.5K ﹤0.01% 799
2019
Q1
$1K Sell
260
-1,610
-86% -$6.97K ﹤0.01% 968
2018
Q4
$9K Buy
+1,870
New +$11.3K ﹤0.01% 565
2018
Q2
Sell
-857
Closed -$9K 1255
2018
Q1
$9K Buy
857
+292
+52% +$2.88K ﹤0.01% 705
2017
Q4
$4K Buy
+565
New +$3.48K ﹤0.01% 630
2017
Q1
Sell
-11,161
Closed -$23K 1057
2016
Q4
$23K Buy
+11,161
New +$22.4K 0.02% 523

Other funds holding IMGN

Point72 Hong Kong's IMGN Position: Q4 2022 in Review

Point72 Hong Kong sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 72,610 shares — an estimated $347K sold.

Point72 Hong Kong first reported a position in IMGN in Q4 2016 and held it in 11 quarters. The position peaked at $347K in Q3 2022. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Point72 Hong Kong reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 72,610 Immunogen Inc shares in Q4 2022, an estimated $347K.
  • Point72 Hong Kong first reported a position in Immunogen Inc in Q4 2016 and held it in 11 quarters.
  • Point72 Hong Kong's Immunogen Inc position peaked at $347K in Q3 2022.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.